2014
DOI: 10.1152/ajpgi.00317.2013
|View full text |Cite
|
Sign up to set email alerts
|

Cannabinoid-induced autophagy regulates suppressor of cytokine signaling-3 in intestinal epithelium

Abstract: Koay LC, Rigby RJ, Wright KL. Cannabinoid-induced autophagy regulates suppressor of cytokine signaling-3 in intestinal epithelium. Am J Physiol Gastrointest Liver Physiol 307: G140-G148, 2014. First published May 15, 2014; doi:10.1152/ajpgi.00317.2013.-Autophagy is a catabolic process involved in homeostatic and regulated cellular protein recycling and degradation via the lysosomal degradation pathway. Emerging data associate impaired autophagy, increased activity in the endocannabinoid system, and upregulatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
21
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 29 publications
(22 citation statements)
references
References 50 publications
1
21
0
Order By: Relevance
“…Evidence shows that autophagy is reduced in aged tissues and that rapamycin, and hence mTOR inhibition, increases lifespan mainly through induction of autophagy 95 . Interestingly, autophagy measured in cancer cells is also induced by eCB signalling 9698 . However, the underlying mechanism of this latter response is unlikely to involve the above-mentioned CB1 activation of mTOR, as this mechanism inhibits (rather than stimulates) autophagy.…”
Section: Ecb Signalling Cell Metabolism and Diseasementioning
confidence: 99%
“…Evidence shows that autophagy is reduced in aged tissues and that rapamycin, and hence mTOR inhibition, increases lifespan mainly through induction of autophagy 95 . Interestingly, autophagy measured in cancer cells is also induced by eCB signalling 9698 . However, the underlying mechanism of this latter response is unlikely to involve the above-mentioned CB1 activation of mTOR, as this mechanism inhibits (rather than stimulates) autophagy.…”
Section: Ecb Signalling Cell Metabolism and Diseasementioning
confidence: 99%
“…Pharmacological inhibition or genetic deletion of CB 1 receptors was associated with attenuated diabetes-induced myocardial inflammation, decreased MAPK activation, oxidative/nitrative stress, β-MHC isoenzyme switch, AT 1 R up-regulation, myocardial RAGE and AGE expression/accumulation, MAPK activation, and largely diminished cell death and better preservation of cardiac function [38]. Recent studies indicate that cannabinoids (especially CB1 agonists) may be important inductors of autophagy in preimplantation mouse embryos [138] and in human epithelial colorectal adenocarcinoma cells (CaCo2) [139]. Although, the evidences outlined here clearly show that inflammation is one of the key therapeutically important components associated with diabetic cardiomyopathy, to see if pharmacologic modulation of cytokine as well as cannabinoid signalling and thereby autophagy has therapeutic potential, further experimental studies are required.…”
Section: Inflammation In Diabetic Cardiomyopathymentioning
confidence: 99%
“…Within 2 wk, 3 to 4 clonal populations of cells were selected, passaged, and cultured for experiments with continued selection pressure. Transfection efficiency was checked by immunoblotting for CB 1 receptor expression using CB 1 receptor antibody (1: 1000, 10006590; Cambridge Bioscience, Cambridge, United Kingdom) (29). Two clones were further assessed for CB 1 receptor knockdown by the [ 35 S] GTP‐γS binding assay using the synthetic CB 1 receptor agonist arachidonyl‐2'‐chloroethylamide as described in Shore et al (30).…”
Section: Methodsmentioning
confidence: 99%